Invesco’s Dianthus Therapeutics DNTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $390K | Buy |
20,940
+4,962
| +31% | +$92.4K | ﹤0.01% | 3272 |
|
|
2025
Q1 | $290K | Buy |
15,978
+4,457
| +39% | +$80.9K | ﹤0.01% | 3355 |
|
|
2024
Q4 | $251K | Buy |
11,521
+790
| +7% | +$17.2K | ﹤0.01% | 3451 |
|
|
2024
Q3 | $294K | Sell |
10,731
-404
| -4% | -$11.1K | ﹤0.01% | 3411 |
|
|
2024
Q2 | $288K | Buy |
+11,135
| New | +$288K | ﹤0.01% | 3506 |
|
|
2022
Q2 | – | Sell |
-708
| Closed | -$33K | – | 4032 |
|
|
2022
Q1 | $33K | Buy |
708
+14
| +2% | +$653 | ﹤0.01% | 3921 |
|
|
2021
Q4 | $49K | Sell |
694
-116
| -14% | -$8.19K | ﹤0.01% | 3946 |
|
|
2021
Q3 | $95K | Buy |
810
+125
| +18% | +$14.7K | ﹤0.01% | 3914 |
|
|
2021
Q2 | $107K | Buy |
+685
| New | +$107K | ﹤0.01% | 3854 |
|
|
2019
Q2 | – | Sell |
-3,341
| Closed | -$880K | – | 3683 |
|
|
2019
Q1 | $880K | Buy |
+3,341
| New | +$880K | ﹤0.01% | 3069 |
|